About this Medicine article
Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program by Conaghan, Philip G. (author);Mysler, Eduardo (author);Tanaka, Yoshiya (author);Da Silva-Tillmann, Barbara (author);Shaw, Tim (author);Liu, John (author);Ferguson, Ryan (author);Enejosa, Jeffrey V. (author);Cohen, Stanley (author);Nash, Peter (author);Rigby, William (author);Burmester, Gerd (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Conaghan, Philip G. (author);Mysler, Eduardo (author);Tanaka, Yoshiya (author);Da Silva-Tillmann, Barbara (author);Shaw, Tim (author);Liu, John (author);Ferguson, Ryan (author);Enejosa, Jeffrey V. (author);Cohen, Stanley (author);Nash, Peter (author);Rigby, William (author);Burmester, Gerd (author)
- Publisher
- Springer Science and Business Media LLC
- Published
- 2021
- Field
- Medicine (Health Sciences)